1,3,4-oxadiazole has been researched along with Disease Models, Animal in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YL; Duan, YJ; Li, QS; Liu, ZG; Meng, HW; Meng, XS; Shen, ZB; Wang, TX; Wang, XR; Yang, XX; Yin, ZQ; Zhang, S; Zou, TF | 1 |
| Choubey, PK; Seth, A; Shrivastava, SK; Tripathi, A; Tripathi, MK | 1 |
| Bader, M; Celik, T; Dedeoglu-Erdogan, A; Gurdal, EE; Koksal, M; Ozgurbuz, M; Reis, R; Sipahi, H; Sippl, W | 1 |
| Alam, MS; Dhulap, A; Hamid, H; Kalam, A; Khan, I; Tantray, MA | 1 |
| Bhutani, R; Husain, A; Iqbal, MA; Kapoor, G; Pathak, DP | 1 |
| Baev, DS; Frolova, TS; Popov, SA; Semenova, MD; Shults, EE; Sorokina, IV; Tolstikova, TG; Turks, M; Zhukova, NA | 1 |
| Banerjee, AG; Das, N; Shengule, SA; Shrivastava, SK; Srivastava, RS | 1 |
7 other study(ies) available for 1,3,4-oxadiazole and Disease Models, Animal
| Article | Year |
|---|---|
Novel flavonoid 1,3,4-oxadiazole derivatives ameliorate MPTP-induced Parkinson's disease via Nrf2/NF-κB signaling pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anti-Inflammatory Agents; Antioxidants; Disease Models, Animal; Flavonoids; Inflammation; Mice; Mice, Inbred C57BL; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Parkinson Disease; Signal Transduction | 2023 |
Design, synthesis, and evaluation of N-benzylpyrrolidine and 1,3,4-oxadiazole as multitargeted hybrids for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Butyrylcholinesterase; Cholinesterase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Design; Female; Humans; Male; Maze Learning; Molecular Structure; Neuroprotective Agents; Oxadiazoles; Peptide Fragments; Pyrrolidines; Rats; Rats, Wistar; Structure-Activity Relationship | 2021 |
Design, synthesis, and molecular docking of novel 3,5-disubstituted-1,3,4-oxadiazole derivatives as iNOS inhibitors.
Topics: Animals; Anti-Inflammatory Agents; Carrageenan; Disease Models, Animal; Edema; Enzyme Inhibitors; Indomethacin; Inflammation; Macrophages; Male; Mice; Mice, Inbred BALB C; Molecular Docking Simulation; Nitric Oxide Synthase Type II; Oxadiazoles; RAW 264.7 Cells; Structure-Activity Relationship | 2021 |
Synthesis of benzimidazole-linked-1,3,4-oxadiazole carboxamides as GSK-3β inhibitors with in vivo antidepressant activity.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glycogen Synthase Kinase 3 beta; Hindlimb Suspension; Humans; Male; Molecular Dynamics Simulation; Molecular Structure; Oxadiazoles; Rats; Rats, Wistar; Recombinant Proteins; Structure-Activity Relationship | 2018 |
Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment.
Topics: Administration, Oral; Animals; Benzothiazoles; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Glucose Tolerance Test; Hypoglycemic Agents; Male; Molecular Docking Simulation; Molecular Structure; Oxadiazoles; Rats; Rats, Wistar; Streptozocin; Structure-Activity Relationship; Thiazolidines | 2019 |
Lupane-type conjugates with aminoacids, 1,3,4- oxadiazole and 1,2,5-oxadiazole-2-oxide derivatives: Synthesis, anti-inflammatory activity and in silico evaluation of target affinity.
Topics: Amino Acids; Animals; Anti-Inflammatory Agents; Computer Simulation; Concanavalin A; Disease Models, Animal; Edema; Female; Fibroblasts; Histamine; Inflammation; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Molecular Conformation; Molecular Docking Simulation; NF-E2-Related Factor 2; NF-kappa B; Oxadiazoles; Triterpenes | 2019 |
Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Carrageenan; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Formaldehyde; Kinetics; Mice; Molecular Dynamics Simulation; Molecular Structure; Oxadiazoles; Pain; Rats; Stomach Ulcer; Structure-Activity Relationship; Triazines | 2015 |